Sign Out
Women of child-bearing potential, pregnancy, breastfeeding and fertility women of child-bearing potential: Women of child-bearing potential must be advised to use highly effective contraception during treatment. Highly effective contraception is a method of birth control which results in a low failure rate (i.e. less than 1% per year), when used consistently and correctly.
Fertility: Male patients concerned about their fertility on Imatinib treatment should consult with their physician.
Use in pregnancy: Imatinib should be used during pregnancy only if the expected benefit outweighs the potential risk to the fetus. If it is used during pregnancy, the patient must be informed of the potential risk to the fetus.
Use in breastfeeding: Both Imatinib and its active metabolite can be distributed into human milk. Since the effects of low-dose exposure of the infant to Imatinib are unknown, women taking Imatinib should not breastfeed.
